(Q34106526)

31 July 2017

title

Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis (English)

1 reference

31 July 2017

1 reference

1 reference

Silke C Mueller

1

1 reference

31 July 2017

Jolanta Majcher-Peszynska

2

1 reference

31 July 2017

Heiko Hickstein

3

1 reference

31 July 2017

Astrid Francke

4

1 reference

31 July 2017

Annette Pertschy

5

1 reference

31 July 2017

Martin Schulz

6

1 reference

31 July 2017

Ralf Mundkowski

7

1 reference

31 July 2017

Bernd Drewelow

8

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

46

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

1557-1560

1 reference

Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

A primer on continuous renal replacement therapy for critically ill patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: studies with piperacillin-tazobactam and piperacillin-sulbactam.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Principles of drug administration in renal insufficiency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Piperacillin/tazobactam: a critical review of the evolving clinical literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Piperacillin-Tazobactam: a new beta-lactam-beta-lactamase inhibitor combination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairment.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127124

High-performance liquid chromatographic determination of tazobactam by precolumn derivatization

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11959598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11959598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11959598

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.46.5.1557-1560.2002

1 reference

31 July 2017

1 reference

31 July 2017

1 reference